⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

JNJ

Johnson & Johnson

Healthcare · Drug Manufacturers - General

267.08USD

-2.0400 (-0.76%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 267.08
P/E30.6
Dvd Ind Yld2.0%
P/B7.57
P/S6.6
Curr EV/T12M EBITDA26.5
Mkt Cap (USD)643.6B
Curr EV (USD)676.8B
2)

Per Share Data

EPS T12M8.64
DPS5.36
Bk Val Per Sh35.28
Rev/Sh40.13
Cash/Sh8.61
Curr Shares Out2,409.9M
FCF/Sh9.12
3)

Cash Flow Analysis

P/CF23.3
Curr P/FCF28.9
CF/NI1.3
Dvd P/O60.8%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales28.2%
Eff Interest Rate2.0%
4)

Growth Potential

Dil EPS 1Y Gr90.5%
Cap 1Y Gr19.7%
BPS 1Y Gr14.1%
R&D To Sales0.1%
Retention Rate39.2%
Rev 1Y Gr6.0%
FCF 1Y Gr-0.7%
Assets 1Y Gr10.6%
5)

Profitability

EBITDA25.5B
EBIT21.8B
Operating Margin22.2%
Pretax Margin25.7%
Net Margin21.5%
ROA10.7%
ROE25.7%
ROC13.6%
Asset Turnover0.50
6)

Structure

Current Ratio1.09
Quick Ratio0.73
Debt/Assets24.4%
Debt/Com Eq57.7%
Net Debt/EBITDA1.12
Tot Debt/Capital36.6%
Gross Margin67.9%
EBIT/Int Exp21.5

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.